ARKG vs. XLVI
ARKG (ARK Genomic Revolution Multi-Sector ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while XLVI is a Derivative Income fund actively managed by State Street. Both are actively managed. At a 0.42 correlation, their price movements are largely independent. ARKG charges 0.75%/yr vs 0.35%/yr for XLVI.
Performance
ARKG vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKG achieves a 17.09% return, which is significantly higher than XLVI's -0.67% return.
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
XLVI
- 1D
- 0.67%
- 1M
- 2.30%
- YTD
- -0.67%
- 6M
- 0.76%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 18.24% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -0.67% | 12.79% |
Correlation
The correlation between ARKG and XLVI is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 31, 2025 | 0.42 |
ARKG vs. XLVI - Sectors Allocation Comparison
Sectors
ARKG
XLVI
Healthcare
-
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
ARKG
XLVI
-
Financial Services
ARKG
XLVI
Basic Materials
ARKG
-
XLVI
-
Communication Services
ARKG
-
XLVI
-
Consumer Cyclical
ARKG
-
XLVI
-
Consumer Defensive
ARKG
-
XLVI
-
Energy
ARKG
-
XLVI
-
Industrials
ARKG
-
XLVI
-
Real Estate
ARKG
-
XLVI
-
Technology
ARKG
-
XLVI
-
Utilities
ARKG
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. XLVI — Risk / Return Rank
ARKG
XLVI
ARKG vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ARKG | XLVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.22 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.95 | — | — |
| Martin ratioReturn relative to average drawdown | 4.67 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ARKG | XLVI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.31 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.18 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 1.33 | -1.19 |
Drawdowns
ARKG vs. XLVI - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for ARKG and XLVI.
Loading charts...
Drawdown Indicators
| ARKG | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | -8.14% | -75.45% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -69.65% | -4.02% | -65.63% |
Average DrawdownAverage peak-to-trough decline | -35.87% | -1.95% | -33.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.46% | — | — |
Volatility
ARKG vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| ARKG | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.90% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 41.12% | 10.94% | +30.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.61% | 10.94% | +34.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.12% | 10.94% | +30.18% |
ARKG vs. XLVI - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
ARKG vs. XLVI - Dividend Comparison
ARKG has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.53%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.53% | 5.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKG and XLVI have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.75% for ARKG.
XLVI has the higher dividend yield at 11.53%, compared with 0.00% for ARKG.
ARKG is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: ARK and State Street. Their fees differ too: 0.75% for ARKG and 0.35% for XLVI.
Find the right allocation for ARKG and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer